Showing 461 - 480 results of 34,158 for search '"Hepatitis"', query time: 0.17s Refine Results
  1. 461
  2. 462
  3. 463
  4. 464

    PIMT regulates hepatic gluconeogenesis in mice by Bandish Kapadia, Soma Behera, Sireesh T. Kumar, Tapan Shah, Rebecca Kristina Edwin, Phanithi Prakash Babu, Partha Chakrabarti, Kishore V.L. Parsa, Parimal Misra

    Published 2023-03-01
    “…The PKA-PIMT-Ep300 signaling module and associated PIMT regulation may serve as a key driver of gluconeogenesis, positioning PIMT as a critical hepatic glucose sensor.…”
    Get full text
    Article
  5. 465
  6. 466

    Benign Hepatic Neoplasms: An Imaging Review by Rajendra Kumar Behera, Stuti Chandola, Ankur Goyal, Raju Sharma

    Published 2023-05-01
    “…Radiologists should also be acquainted with features of rare hepatic neoplasms like angiomyolipoma, paraganglioma, and inflammatory pseudotumor. …”
    Get full text
    Article
  7. 467
  8. 468
  9. 469

    BLOOD DONOR SCREENING FOR HEPATITIS AND HIV by Mehwish Azam, Nousheen Jamal, Fauzia Imtiaz, Zeba Haque, Zeenat Ayoob

    Published 2007-09-01
    “…Donors that have any disease such as viral hepatitis, malaria, venereal disease, AIDS are excluded from blood donation2. …”
    Get full text
    Article
  10. 470

    Innovations in Hepatitis C Screening and Treatment by Arpan A. Patel, Aileen Bui, Eian Prohl, Debika Bhattacharya, Su Wang, Andrea D. Branch, Ponni V. Perumalswami

    Published 2021-03-01
    “…New therapies offer hope for a cure to millions of persons living with hepatitis C virus (HCV) infection. HCV elimination is a global goal that will be difficult to achieve using the traditional paradigms of diagnosis and care. …”
    Get full text
    Article
  11. 471

    Betaleukin in therapy of chronic hepatitis C by E. S. Romanova, N. I. Kuznetsov, G. Yu. Startseva

    Published 2014-10-01
    “…The article presents the problems of modern antiviral therapy of chronic hepatitis C. The effectiveness of combined therapy with pegylated interferon and ribavirin in patients infected with 1st genotype is not more than 50%. …”
    Get full text
    Article
  12. 472
  13. 473

    EXPERIMENTAL APPROACHES TO IMMUNOPHARMACOTHERAPY FOR TOXIC HEPATITIS by S. Yu. Dyachkova, A. V. Turovsky

    Published 2015-09-01
    “…Humoral and cellular factors of natural resistance in different blood vessels for experimental CCl4-hepatitis have been studied. Sharp decrease of all factors have been detected with prevailing suppression of cellular link in lever veins and gradual increase of lysozime by 14 days which supposes the use of corresponding immunoprotectors in post-desintoxication period.…”
    Get full text
    Article
  14. 474

    Imaging Features of Rare Hepatic Tumors by Raghunandan Vikram, Achal Sarna, Nir Stanietzky

    Published 2023-09-01
    “…Hepatic lesions are commonly encountered in radiology practice. …”
    Get full text
    Article
  15. 475
  16. 476
  17. 477
  18. 478
  19. 479
  20. 480